CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Real estate owned:
Real estate held for investment	$ 15,565,915	$ 15,365,928
Less: accumulated depreciation	(5,926,651)	(5,762,205)
Real estate held for investment, net	9,639,264	9,603,723
Real estate under development (net of accumulated depreciation of $0 and $296, respectively)	76,455	189,809
Real estate held for disposition (net of accumulated depreciation of $0 and $0, respectively)		14,039
Total real estate owned, net of accumulated depreciation	9,715,719	9,807,571
Cash and cash equivalents	1,172	1,193
Restricted cash	28,038	29,001
Notes receivable, net	71,125	54,707
Investment in and advances to unconsolidated joint ventures, net	751,387	754,446
Operating lease right-of-use assets	193,230	194,081
Other assets	207,029	197,471
Total assets	10,967,700	11,038,470
Liabilities:
Secured debt, net	1,051,000	1,052,281
Unsecured debt, net	4,525,963	4,435,022
Operating lease liabilities	188,402	189,238
Real estate taxes payable	35,052	37,681
Accrued interest payable	26,580	46,671
Security deposits and prepaid rent	57,738	51,999
Distributions payable	148,409	134,213
Accounts payable, accrued expenses, and other liabilities	111,795	153,220
Total liabilities	6,144,939	6,100,325
Commitments and contingencies (Note 13)
Redeemable noncontrolling interests in the Operating Partnership and DownREIT Partnership	901,652	839,850
Equity:
Common stock, $0.01 par value; 450,000,000 shares authorized at March 31, 2023 and December 31, 2022: 329,173,125 and 328,993,088 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively	3,292	3,290
Additional paid-in capital	7,494,042	7,493,423
Distributions in excess of net income	(3,627,873)	(3,451,587)
Accumulated other comprehensive income/(loss), net	6,823	8,344
Total stockholders' equity	3,920,899	4,098,085
Noncontrolling interests	210	210
Total equity	3,921,109	4,098,295
Total liabilities and equity	10,967,700	11,038,470
8.00% Series E Cumulative Convertible Preferred Stock
Equity:
Preferred stock, no par value; 50,000,000 shares authorized at March 31, 2023 and December 31, 2022:	44,614	44,614
Series F
Equity:
Preferred stock, no par value; 50,000,000 shares authorized at March 31, 2023 and December 31, 2022:	$ 1	$ 1